In one paragraphArticle in Science advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from itWhat it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
14 authors.
Markus MeierDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0009-0003-8292-2489 Scott A ScholzDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0000-0001-9168-9285 Leo von BankDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0009-0000-3307-4266 João E LevandoskiDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0000-0001-8023-7355 Mosche LückhofInstitute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL); Hans-Meerwein-Straße 2, D-35043 Marburg, Germany.ORCID 0009-0005-1127-2508 Maximilian SchaafDepartment Physical Chemistry of Polymers, Max Planck Institute for Polymer Research; Ackermannweg 10, D-55128 Mainz, Germany.
Nataliya SafronovaDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0000-0001-7372-3857 Nathan F GreenwoodDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0009-0005-2167-3647 Shutian SiDepartment Physical Chemistry of Polymers, Max Planck Institute for Polymer Research; Ackermannweg 10, D-55128 Mainz, Germany.
Ingo LieberwirthDepartment Physical Chemistry of Polymers, Max Planck Institute for Polymer Research; Ackermannweg 10, D-55128 Mainz, Germany.ORCID 0000-0003-1323-524X Anna Lena JungInstitute for Lung Research, Universities of Giessen and Marburg Lung Center, Philipps-University Marburg, German Center for Lung Research (DZL); Hans-Meerwein-Straße 2, D-35043 Marburg, Germany.ORCID 0000-0002-7762-4597 Katharina LandfesterDepartment Physical Chemistry of Polymers, Max Planck Institute for Polymer Research; Ackermannweg 10, D-55128 Mainz, Germany.ORCID 0000-0001-9591-4638 Arnold J M DriessenDepartment of Molecular Microbiology, Groningen Biomolecular Sciences and Biotechnology Institute, University of Groningen; Nijenborgh 7, 9747AG Groningen, Netherlands.ORCID 0000-0001-9258-9104 Tobias J ErbDepartment of Biochemistry & Synthetic Metabolism, Max Planck Institute for Terrestrial Microbiology; Karl-von-Frisch-Str. 10, D-35043 Marburg, Germany.ORCID 0000-0003-3685-0894 Funding
No grant is acknowledged in the PubMed record.
6 · The paper itselfAbstract
Almost all membrane proteins are inserted or translocated across membranes by the universally conserved Sec translocon. Despite its central role, experimental access to Sec function has remained limited. Here, we present ProSecCO (Protein Secretion in Cell-free via synthetic Operons), which is a cell-free protein synthesis platform that inserts SecYEG into synthetic vesicles, enabling direct testing of Sec in real-time and high-throughput, circumventing longstanding viability constraints. Screening 300 Sec variants in a single experiment, we consolidate three decades of Sec research, while vastly expanding mutant diversity for structure-function insights. Mapping over 30 functionally critical regions that modulate Sec activity across three orders of magnitude, we uncover dozens of super-active translocation variants and one variant of improved insertion activity. We further leverage ProSecCO to increase membrane protein quality and nanobody export, highlighting the potential of our system for advancing applications in synthetic biology and biotechnology.
Indexed as
Protein EngineeringSEC Translocation ChannelsCell-Free SystemEscherichia coliMembrane ProteinsProtein TransportMembrane ProteinsSEC Translocation Channels
Identifiers
PMID42685219
PMCPMC13537251
What OpenQuestion holds
Textmetadata
Read underepoch 390